ResMed Inc. operates as a global leader in digital health and cloud-connected medical devices.
The company designs innovative solutions to treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. The compan…
Analysis
Quality compounder
ResMed Inc. earns the quality_compounder label: good underlying economics priced fairly, with no obvious bargain or excess. Worth noting: the cash the business generates has lagged behind what the income statement shows.
On valuation, the picture is fair. The owner-earnings multiple stands at 17.6×; owner earnings: the cash an owner could take out each year. The implied growth embedded in that price is around 5% a year, against analyst forecasts of 14%. The price, in other words, assumes less than the experts do.
Growth is moderate; the safety picture is sturdy. The company scores 12/20 on our value-creation score: creating some value.
Flags to be aware of: Reported profits have run ahead of actual cash for several periods. As always: this describes the company's numbers; it is not a recommendation.
360° rank · history
1007550250
Jan 202339
100
2023202420252026
All-time high
100
Mar 2026
All-time low
39
Jan 2023
Average rank
90
across all years
Detailed & Historical Ranks
Deep dive into 15 detailed ranks and 3 years of history.
Current202520242023
Price/Sales
32
24
34
27
Price/Earnings
32
54
48
42
Price/Book
39
32
38
37
Dividend Yield
99
92
88
89
Value (overall)
65
62
59
67
Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.